BETA 2 GLYCOPROTEIN – IGG

The Beta 2 Glycoprotein IgG test detects specific autoantibodies in the blood that are associated with Antiphospholipid Syndrome (APS). These antibodies can cause excessive blood clotting and recurrent miscarriages.

This test is recommended to:

• Diagnose antiphospholipid syndrome (APS)
• Evaluate risk of abnormal blood clotting
• Investigate recurrent thrombosis
• Assess autoimmune disorders affecting blood vessels
• Support diagnosis of unexplained clotting events

BETA 2 GLYCOPROTEIN – IGG Test Purpose

The Beta-2 Glycoprotein – IgG Test measures IgG antibodies directed against beta-2 glycoprotein I, a protein that plays an important role in the body’s blood clotting process. The presence of these antibodies may indicate an abnormal immune response and is strongly associated with Antiphospholipid Syndrome (APS), an autoimmune disorder that increases the risk of arterial and venous blood clots, as well as pregnancy-related complications.

Healthcare providers commonly recommend this test for individuals with unexplained deep vein thrombosis (DVT), pulmonary embolism, stroke at a young age, recurrent miscarriages, stillbirths, preeclampsia, or other pregnancy complications. It is also valuable for evaluating patients with autoimmune diseases, particularly Systemic Lupus Erythematosus (SLE), where antiphospholipid antibodies are more frequently detected.

Furthermore, the Beta-2 Glycoprotein I IgG Test is one of the primary laboratory tests used in the diagnosis of Antiphospholipid Syndrome (APS). Persistent IgG antibody positivity, especially when confirmed on repeat testing after at least 12 weeks, together with compatible clinical findings, supports the diagnosis of APS.

The Beta-2 Glycoprotein I IgG Test is often performed alongside Beta-2 Glycoprotein I IgM and IgA, Anticardiolipin Antibodies (IgG, IgM, and IgA), Lupus Anticoagulant Testing, ANA, and other autoimmune or coagulation studies to provide a comprehensive evaluation.

BETA 2 GLYCOPROTEIN – IGG Test is Recommended for Individuals:

• Individuals with unexplained blood clots or recurrent thrombosis.
• Women with recurrent miscarriages, stillbirths, or pregnancy complications.
• Patients suspected of having Antiphospholipid Syndrome (APS).
• Individuals with Systemic Lupus Erythematosus (SLE) or other autoimmune diseases.
• Patients with stroke or transient ischemic attack (TIA) at a young age.
• Individuals with unexplained clotting abnormalities.
• Patients advised by their healthcare provider to undergo antiphospholipid antibody testing.

FAQs

1. What is the Beta-2 Glycoprotein IgG Test used for?

The Beta-2 Glycoprotein I IgG Test detects IgG antibodies against beta-2 glycoprotein I. It helps diagnose Antiphospholipid Syndrome (APS), assess the risk of abnormal blood clotting, and evaluate pregnancy-related complications associated with autoimmune disorders.

2. Do I need to fast before the Beta-2 Glycoprotein IgG Test?

No. Fasting is generally not required for this blood test. However, always follow any preparation instructions provided by your healthcare provider before sample collection.

3. What does a positive Beta-2 Glycoprotein IgG result mean?

A positive result indicates the presence of Beta-2 Glycoprotein I IgG antibodies, which may be associated with Antiphospholipid Syndrome (APS) or other autoimmune conditions. However, the result alone does not confirm the diagnosis. Your healthcare provider will interpret the findings along with your symptoms, medical history, pregnancy history, and results of other antiphospholipid antibody tests. In many cases, repeat testing after 12 weeks is recommended to confirm persistent antibody positivity.